Ageing of old community (seniorization) and geriatrization of medicine.

Czech version

Authors: P. Weber
Authors‘ workplace: Klinika interní, geriatrie a praktického lékařství LF MU a FN Brno
Published in: Geriatrie a Gerontologie 2018, 7, č. 4: 152-155
Category: Review Article

Overview

In the elderly population, a functional decline is common, more diseases add up gradually towards genuine multimorbidity and there is a growing number of social problems (loneliness, a loss of partners etc.) which can emphasize old age frailty and inability to live independently without other people´s assistance. Geriatric medicine is aimed at optimization of residual functions despite general functional decline connected with ageing and multimorbidity. Modern civilization substantially supports hopes of achieving late old age and the life expectancy grows constantly. Numbers of old and very old people grow absolutely and relatively as well which is a trend that requires an appropriate approach of not only medicine but also the whole of society in forthcoming decades.

Keywords:

geriatrization of medicine – geriatric syndromes – demografic situation and prognosis in the Czech Republic – Brno Geriatric Day

Sources

1. Cassel CHK, Leipzig R, Cohen HJ (eds.) Geriatric medicine: an evidence-based approach paperback softcover reprint of the original 4th ed. New York, Springer-Verlag Inc 2013.

2. Ng SK, Tawiah R, Sawyer M, Scuffham P. Patterns of multimorbid health conditions: a systematic review of analytical methods and comparison analysis. Int J Epidemiol. 2018. [Epub ahead of print]

3. Pathy MS John, Finucane P (eds.) Geriatric Medicine: Problems and Practice paperback. NY: Springer 2014.

4. Morley JE, Caplan G. Cesari M. International Survey of Nursing Home Research Priorities. JAMDA 2014; 15(5): 309–312.

5. Blanco-Reina E, Ariza-Zafra G, Ocaña-Riola R, et al. Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related? Eur J Clin Pharmacol 2015; 71(2): 199–207.

6. Hovstadius B, Petersson G, Hellström L, Ericson L. Trends in inappropriate drug therapy prescription in the elderly in Sweden from 2006 to 2013: assessment using national indicators. Drugs Aging 2014; 31(5): 379–386.

7. Geeson C, Wei L, Franklin BD. Medicines Optimisation Assessment Tool (MOAT): a prognostic model to target hospital pharmacists‘ input to improve patient outcomes. Protocol for an observational study. BMJ Open 2017; 7(6): 017509.

8. Manias E, Kusljic S, Berry C, et al. Use of the Screening Tool of Older Person‘s Prescriptions (STOPP) in older people admitted to an Australian hospital. Australas J Ageing 2015; 34(1): 15–20.

9. Zrubáková K, Krajčík Š a kol. Farmakoterapie v geriatrii. Praha: Grada 2016.

10. Huiskes VJ, Burger DM, van den Ende CH, van den Bemt BJ. Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials. BMC Fam Pract 2017; 18(1): 5.

11. Topinková E. Jak zlepšit adherenci k lékovému režimu u klinicky komplexních polymorbidních seniorů? Vnitr Lek 2013; 59(9): 760–763.

12. Expert Panel American Geriatrics Society, Expert Panel on the Care of Older Adults with Multimorbidity. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. J Am Geriatr Soc 2012; 60: 10: E1–E25.

13. Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev 2011; 10(4): 430–439.

14. Rutenberg AD, Mitnitski AB, Farrell SG, Rockwood K. Unifying aging and frailty through complex dynamical networks. Exp Gerontol 2018; 107: 126–129.

15. Heiss HW (ed). Altersmedizin aktuell. Interdisziplinäre geriatrische Versorgung, 32. Ergänzungslieferung. Heidelberg, München, Landsberg, Frechen, Hamburg: Ecomed MEDIZIN 2014.

16. Lally F, Roffe Ch (eds.). Geriatric Medicine: an evidence-based approach. London: Oxford University Press 2014.

17. Williams B, Chang A, Landefeld C (eds.) Current Diagnosis and Treatment: Geriatrics 2E. McGraw-Hill Education /Medical 2014.

18. Fried TR, Tinetti ME, Iannone L, et al. Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions. Arch Intern Med 2011; 171(20): 1854–1856.

19. Evans DC, Cook CH, Christy JM, et al. Comorbidity-polypharmacy scoring facilitates outcome prediction in older trauma patients. J Am Geriatr Soc 2012; 60(8): 1465–1470.

20. Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173: 489–495.

21. Fried LP, Ferrucci L, Darer J. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004; 59(3): 255–263.

22. Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013; 14(6): 392–397.

23. Jadad AR, To MJ, Emara M, Jones J. Consideration of multiple chronic diseases in randomized controlled trials. JAMA 2011; 306 (24): 2670–2672.

24. Gómez C, Vega-Quiroga S, Bermejo-Pareja F, et al. Polypharmacy in the Elderly: A Marker of Increased Risk of Mortality in a Population-Based Prospective Study (NEDICES). Gerontology 2015; 61(4): 301–309.

25. Jørgensen R, Brabrand M. Screening of the frail patient in the emergency department: A systematic review. Eur J Intern Med. 2017; 4: 71–73.

26. Haaksma ML, Rizzuto D, Ramakers IHGB, Garcia-Ptacek S, Marengoni A, van der Flier WM, Verhey FRJ, Olde Rikkert MGM, Melis RJF. The Impact of Frailty and Comorbidity on Institutionalization and Mortality in Persons With Dementia: A Prospective Cohort Study. J Am Med Dir Assoc. 2018. pii: S1525-8610(18)30358-X. [Epub ahead of print]

27. Frost R, Belk C, Jovicic A, Ricciardi F, Kharicha K, Gardner B, Iliffe S, Goodman C, Manthorpe J, Drennan VM, Walters K. Health promotion interventions for community-dwelling older people with mild or pre-frailty: a systematic review and meta-analysis. BMC Geriatr. 2017; 17(1): sy dekondice 157.

28. Barbagallo M, Dominguez LJ, Cucinotta D. The place of frailty and vulnerability in the surgical risk assessment: should we move from complexity to simplicity? Aging Clin Exp Res 2018; 30(3): 237–239.

29. Weber P, Ambrošová P, Weberová D, et al. Geriatrické syndromy a syndrom frailty – zlatý grál geriatrické medicíny. Vnitř Lék 2011; 57 (6): E2010_18 online.

30. Kastner M, Cardoso R, Lai Y, et al. Effectiveness of interventions for managing multiple high-burden chronic diseases in older adults: a systematic review and meta-analysis. CMAJ 2018; 190(34): 1004–1012.

31. Zdravotnická ročenka ČR 2016. Praha: ÚZIS ČR 2016.

32. Český statistický úřad. [Citováno 2015-06-07]. Dostupné z: www.czso.cz.

33. Weber P, Prudius D, Meluzínová H. Geriatrická multimorbidita – jeden z klíčových problémů současné medicíny. Vnitř Lék 2015; 61(12): 1042–1048.